Aap Implantate Ag · XETR:AAQ1
Aap Implantate — FY2018 Earnings Presentation
11 slides from Aap Implantate's earnings presentation, Apr 30, 2019
Slide 1: Annual Financial Statements FY/2018 Conference Call
aap Implantate AG Annual Financial Statements FY/2018 Conference Call Bruke Seyoum Alemu, CEO Marek Hahn, CFO Berlin, April 30, 2019
Slide 2: Safe Harbor Statement
Safe Harbor Statement Our publication may include predictions, estimates or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual
Slide 3: Key results and progress FY/2018
Key results and progress FY/2018 ➢ Sales and Earnings ▪ Sales of EUR 10.8 million (FY/2017: EUR 10.9 million) and EBITDA of EUR -6.4 million (FY/2017: EUR -6.2 million) ▪ Double-digit growth rates in Germany (+14% yoy) and international key markets (+24% yoy in BRICS and Europe without Germany); Nor
Slide 4: Key results and progress FY/2018
Key results and progress FY/2018 ➢ LOQTEQ® ▪ Focus on, among other things, European approval of various polyaxial LOQTEQ® systems ▪ Development of sterile packaging for implants ▪ Approval applications submitted to FDA (inter alia for foot and periprosthetic system) ▪ Transformation of processes and
Slide 5: Update Q1/2019
Update Q1/2019 ➢ Q1 Sales (preliminary) ▪ Good start to the year with significant Q1 sales growth to EUR 3.5 million (+25% yoy) ▪ All regions contributed with double-digit growth rates: Germany (+14% yoy), International (+28% yoy) and North America (+18% yoy) ➢ Measures to strengthen financial base
Slide 6: Financial Figures FY/2018
Financial Figures FY/2018 (in KEUR) In KEUR FY/2018 FY/2017 Change on year Trauma 10,816 10,648 +2% Germany 2,774 2,427 +14% North America 2,240 3,071 -27% North America distributors 2,172 2,491 -13% North America global partners 68 580 -88% International (without North America) 5,802 5,150 +13% Eur
Slide 7: Highlights FY/2018 (Balance Sheet)
Highlights FY/2018 (Balance Sheet) ➢ Total assets 12/31/2018: EUR 42.2 million (12/31/2017: EUR 50.5 million) → -16% ▪ Non-current assets: slightly increased, but countervailing effects − Capitalized development costs: EUR +1.3 million − Share of intangible assets in total assets: 31% − Tangible ass
Slide 8: Highlights FY/2018 (Cash Flow)
Highlights FY/2018 (Cash Flow) ➢ Operating Cash Flow FY/2018: EUR -5.9 million (FY/2017: EUR -5.4 million) ▪ Slightly lower operating result (EBIT) ▪ Positive contribution from working capital of EUR 0.6 million → reduction of inventory (EUR +0.3 million), increasing receivables (EUR -0.1 million) a
Slide 9: Management Agenda 2019
Management Agenda 2019 Implementation of strategic imperatives Products Customers Accelerating Value-based Innovation Enhancing Enhancing Market Market Access Access ➢ Silver coating technology – Application on LOQTEQ®: ➢ ➢ Established countries: Focus on DACH, Western Europe Services Germany: Incre
Slide 10: Outlook
Outlook FY/2019 – Sales: EUR 13.0 million – EUR 15.0 million (FY/2018: EUR 10.8 million) − EBITDA: EUR -4.4 million – EUR -2.8 million (FY/2018: EUR -6.4 million) 10
Slide 11: Many thanks for your attention!
Many thanks for your attention! Lorenzweg 5 • 12099 Berlin • Germany Fabian Franke Manager Investor Relations Tel.: +49 30 750 19 – 134 Fax: +49 30 750 19 – 290 E-Mail: ir@aap.de IR-app: 11